The Implementation of Pentavalent Vaccine DTaP/IPV/Hib within National Immunization Schedule

Background. As has been demonstrated by Russian and foreign experience the implementation of combined vaccines within national immunization schedule (NIS) reduces the overall number of injections, enhances vaccination commitment, and as consequence leads to higher vaccination coverage.

Objective.Pharmacoeconomic analysis of planned immunization of children aged from 3 to 18 months with combined diphtheria, pertussis, tetanus, poliomyelitis, haemophilus influenza b vaccine (DTaP/IPV/Hib) within Russian Federation NIS.

Methods. Modelling; estimation economic method: cost analysis, budget impact analysis. Results. Only health system costs on four planned pentavalent vaccines requires application of 1 013 955 985 roubles. From the government and society perspective the change-over to combined vaccine allows to retrench 1 825 385 700 roubles for children aged from 3 to 18 months for all horizon period.

Conclusion. According to budget impact analysis such change-over with controlling only health system costs will require extra expenses. According to government and society perspective (that means social and other expenditures not covered with health system budget) the implementation of scheme of 4-time combined vaccine injections for all cohort allows to reduce cost loading related to infectious disease burden. Present analysis indicated the advisability of pentavalent vaccine implementation for all children within Russian national immunization schedule.

1. Obando-Pacheco P Rivero-Calle I, Gomez-Rial J, et al. New perspectives for hexavalent vaccines. Vaccine. 2018;36(36):5485-5494. doi: 10.1016/j.vaccine.2017.06.063.

2. Maman K, Zollner Y, Greco D, et al. The value of childhood combination vaccines: from beliefs to evidence. Hum Vaccin Immunother. 2015;11(9):2132-2141. doi: 10.1080/21645515.2015.104410.

3. Marshall GS, Happe LE, Lunacsek OE, et al. Use of combination vaccines is associated with improved coverage rates. Pediatr Infect Dis J. 2007;26(6):496-500. doi: 10.1097/INF.0b013e31805d7f17.

4. Happe LE, Lunacsek OE, Marshall GS, et al.Combination vaccine use and vaccination quality in a managed care population. Am J Manag Care. 2007;13(9):506-512.

5. White C, Halperin SA, Scheifele DW. Pediatric combined formulation DTaP-IPV/Hib vaccine. Expert Rev Vaccines. 2009;8(7):831-840. doi: 10.1586/erv.09.59.

6. Dokument po pozitsii VOZ v otnoshenii vaktsinatsii protiv gemofil’noj infektsii tipa b (Hib) — iyul’ 2013 goda [internet]. WHO. European regional office; 2013. 2 p. (In Russ). Доступно по: https://www.who.int/immunization/Hib_Rus.pdf. Ссылка активна на 11.04.2019.

7. Order № 125n Ministry Of Health Russia «Ob utverzhdeniinatsional'nogo kalendarya profilakticheskikh privivok i kalendarya profilakticheskikh privivok po epidemicheskim pokazaniyam» (v redaktsii Prikaza Minzdrava Rossii ot 24.04.2019 № 243n), dated 2014 March 21. (In Russ). Доступно по: http://docs.cntd.ru/document/499086215. Ссылка активна на 15.02.2019.

8. Ozeretskovsky NA, Nemirovskaya TI. Vaccination against Haemophilus influenzae type b in the Russian Federation and abroad. Epidemiologiya i vaktsinoprofilaktika. 2016;15(1):61-66. (In Russ).

9. State report «O sostoyanii sanitarno-epidemio-logicheskogo blagopoluchiya naseleniya v Rossijskoj Federatsii v 2018 godu» (Elektronnyi resurs). Moscow: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya che-loveka; 2019. (In Russ). Доступно по: https://rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=12053. Ссылка активна на 03.06.2019.

10. State report «O sostoyanii sanitarno-epidemio-logicheskogo blagopoluchiya naseleniya v Rossijskoj Federatsii v 2013 godu» (Elektronnyi resurs). Moscow: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya che-loveka; 2014. (In Russ). Доступно по: https://rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=1984. Ссылка активна на 15.02.2019.

11. State report «O sostoyanii sanitarno-epidemiologichesk-ogo blagopoluchiya naseleniya v Rossijskoj Federatsii v 2014 godu» (Elektronnyi resurs). Moscow: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka; 2015. (In Russ). Доступно по: https://rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=3692. Ссылка активна на 15.02.2019.

12. State report «O sostoyanii sanitarno-epidemiologichesk-ogo blagopoluchiya naseleniya v Rossijskoj Federatsii v 2017 godu» (Elektronnyi resurs). Moscow: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka; 2018. (In Russ). Доступно по: https://rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=10145. Ссылка активна на 15.02.2019.

13. Brickley EB, Wright PF. Maximising the impact of inactivated polio vaccines. Lancet Infect Dis. 2017;17(7):680-681. doi: 10.1016/S1473-3099(17)30236-0.

14. Karpova EV, Sarkisyan КА, Movsesyants AA, Merkulov VA. Preventive vaccination against poliomyelitis: modern view. Biopreparaty. 2018;18(4):236-242. (In Russ). doi: 10.30895/2221-996X-2018-18-4-236-242.

15. Stepenko AV, Mindlina AYa. Risk management of the development of epidemiolofical whooping cough process: lost possibilities and new prospects. Meditsinskij al’manakh. 2017;(4):83-86. (In Russ).

16. State report «O sostoyanii sanitarno-epidemio-logicheskogo blagopoluchiya naseleniya v Rossijskoj Federatsii v 2016 godu» (Elektronnyi resurs). Moscow: Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya che-loveka; 2017. (In Russ). Доступно по: https://rospotrebnadzor.ru/documents/details.php?ELEMENTJD=8345. Ссылка активна на 15.02.2019.

17. Instruktsiya po primeneniyu lekarstvennogo preparata po meditsin-skomu primeneniyu Pentaksim: utv. Ministerstvom zdravookhraneni-ya Rossiyskoy Federatsii (elektronnyy resurs). Доступно по: https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=a477b540-df8d-4955-a321-67317ff72322&t=. Ссылка активна на 16.02.2019.

18. Plotkin S, Liese J, Madhi S, Ortiz E. A DTaP-IPV//PRP~T vaccine: a review of 16 years' clinical experience. Current pediatrics. 2012;11(1):18-36. (In Russ).

19. ederal'naya sluzhba gosudarstvennoy statistiki. Ozhidaemaya prodolzhitel'nost1 zhizni pri rozhdenii (elektronnyy resurs). Доступно по: http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/#. Ссылка активна на 23.08.2019/

20. Federal'naya sluzhba gosudarstvennoy statistiki. Rozhdaemost1, smertnost1 i estestvennyy prirost (elektronnyy resurs). Доступно по http://www.gks.ru/wps/wcm/connect/rosstat_main/rosstat/ru/statistics/population/demography/#. Ссылка активна на 23.08.2019/

21. Kulikov AYu, Akimova YI. Pharmacoeconomic analysis of use of pentavalent combination vaccine with acellular pertussis component in the framework of the regional immunization schedule of Krasnodar for all children aged 0-18 months and separatly for children at risk. Pediatric pharmacology. 2014;11(6):30-41. (In Russ).

22. Kulikov AYu, Akimova YuI. Pharmacoeconomic analysis of the use of combination Pentaxim vaccine under the national immunization schedule of the Russian Federation. Epidemiology and infectious diseases. 2014;(4):56-64. (In Russ).

23. Edinaya informatsionnaya sistema v sfere zakupok (elektronnyy resurs). Доступно по: http://www.zakupki. gov.ru. Ссылка активна на 16.02.2019.

24. Kulikov AYu, Akimova YuI. The features of methodology for pharmacoeconomics analysis of vaccination. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2013;6(1):4-10. (In Russ).

25. Gosudarstvennyy reestr lekarstvennykh sredstv (elektronnyy resurs) Доступно по: https://grls.rosminzdrav.ru/grls.aspx. Ссылка активна на 16.02.2019.

26. Prilozhenie № 6 k Tarifnomu soglasheniyu na 2019 god ot 27 dekabrya 2018 g. «Tarify na oplatu meditsinskoypomoshchi, okazyvaemoy v ambulatornykh usloviyakh v ramkakh Territorial'noy programmy OMS, primenyaemye v tom chisle dlya osushchestvleniya gorizontal'nykh raschetov (za isklyucheniem profilya «stomatologiya»)» (elektronnyy resurs). Доступно по: https://www.mgfoms.ru/system/files/prilozhenie_no_6_k_tarifnomu_soglasheniyu_na_2019_god.pdf]. Ссылка активна на 23.08.2019.

27. Tatochenko VK, Namazova LS, Kharit SM, et al. Reactogenity and safety of adsorbed vaccines against diphteria, tetanus and pertussis (dtap): observational multicentral trial. Current Pediatrics. 2006;5(4):32-38. (In Russ).

28. Fedorov AM, Lyashko VV. Vsya pravda o privivkakh. Moscow: Eksmo: Metafora; 2012. 428 р. (In Russ).

29. Edmond K, Clark A, Korczak VS, et al. Global and regional risk of disabling sequelae from bacterial meningitis: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(5):317-328. doi: 10.1016/S1473-3099(10)70048-7.

30. Harit SM, Tchernyaeva TV, Nacharova EP, et al. The estimation of safety booster vaccination children is more senior than 1.5 years against diphtheria, perussis, tetanus, poliomyelitis and Haemophilus influenzae type B with Pentaxim. Zhurnalinfektologii. 2009;1(2-3):73-78. (In Russ).

31. Tarify na oplatu meditsinskoy pomoshchi, okazyvaemoy v statsionarnykh usloviyakh po zakonchennym sluchayam lecheniya zabolevaniya s primeneniem vysokotekhno-logichnoy meditsinskoy pomoshchi v ramkakh Territorial'noy programmy OMS. Prilozhenie № 8.1 k Tarifnomu soglasheniyu na 2019 god ot «29» dekabrya 2018 g. (elektronnyy resurs). Доступно по: https://www.mgfoms.ru/system/files/prilozheniya_no_8.1_k_tarifnomu_soglasheniyu_na_2019_god.pdf. Ссылка активна на 16.02.2019.